Acquire among your professional competences the specialization in Obesity and Diabetes, a unique opportunity to help your patients to control their diet and prevent certain diseases"

Obesity is a health problem that affects people all over the world, although it has a higher incidence in more developed countries, largely due to the lifestyle of citizens and the ability to acquire higher calorie foods. Even so, the World Health Organization (WHO) estimates that it may affect 650 million subjects worldwide, with a related mortality of about 2.8 million subjects per year.

The increase in its incidence, the accompanying comorbidities that lead to a significant increase in mortality, especially cardiovascular and cancer mortality, the various medical and surgical treatments available, together with the exponential increase in health care costs it entails, have made obesity a permanent focus of attention. 

With this in mind, preventing obesity is essential. Through the use of a multidisciplinary approach, the aim is to implement lifestyle changes, especially physical activity and dietary patterns, and should be introduced as early on in the process as possible. Thus, health education has become essential to prevent situations of obesity. 

However, it is also necessary to take into account that obesity can lead to the appearance of other associated diseases, which can cause serious damage to people's health. In this case, with this Advanced master’s degree we want to focus on Diabetes, since it is a complex and chronic process that requires a comprehensive approach by the physician, which goes beyond glycemic control. In fact, type 2 diabetes is the most widespread form of this disease in adult patients, with overweight and obesity as risk factors. Therefore, a healthy lifestyle can prevent their appearance. 

This Advanced master’s degree offers the possibility of deepening and updating knowledge in this area, with the use of the latest educational technology. It offers a global vision of Obesity and Diabetes, while focusing on the most important and innovative aspects to prevent and treat these diseases. All this in a 100% online specialization, which will allow you to expand your knowledge and, therefore, your professional skills and competencies in a simple way, adapting your study time to the rest of your daily obligations. 

This program has been designed for professionals seeking the highest qualification, with the best didactic material, working on real clinical cases and learning from the best professionals in the sector"

This Advanced master’s degree in Obesity and Diabetes contains the most complete and up to date scientific program on the market. The most salient features of the specialization are:  

• The development of clinical cases presented by experts in Obesity and Diabetes.
• The graphic, schematic, and eminently practical contents with which they are created, provide scientific and practical information on the disciplines that are essential for professional practice.
• Diagnostic and therapeutic novelties on Obesity and Diabetes
• The presentation of hands-on workshops on procedures, diagnostic and therapeutic techniques
• Real images in high resolution and practical exercises where the self-evaluation process can be carried out to improve learning.
• An algorithm-based interactive learning system for decision-making in the clinical situations presented throughout the course.
• Special emphasis on evidence-based medicine and research methodologies
• Theoretical lessons, questions to the expert, forums for discussion of controversial issues and individual reflection papers.
• The availability of access to content from any fixed or portable device with an Internet connection.

This program has been designed for professionals seeking the highest qualification, with the best didactic material, working on real clinical cases and learning from the best professionals in the sector"

Its teaching staff includes health professionals from the medical field, who contribute their work experience to this specialization, as well as renowned specialists from leading scientific societies. 

Its multimedia content, developed with the latest educational technology, will allow the professional a situated and contextual learning, that is, a simulated environment that will provide an immersive learning programmed to train in real situations. 

The design of this program focuses on Problem-Based Learning, by means of which the physician must try to solve the different professional practice situations that arise throughout the specialization. For this, the professional will be assisted by an innovative interactive video system developed by recognized experts in the field of Obesity and Diabetes, with extensive teaching experience. 

Increase your confidence in decision making by updating your knowledge through this Grand Master, a program created to train the best"

We offer you the best teaching methodology, with a multitude of practical contents that will allow you to study in a more complete and effective way"

The structure if the contents has been designed by a team of professionals from the best research centers and universities on a national level. Aware of the relevance of the current specialization and the need to support each study and its application on a solid scientific basis, based on evidence, they have created a didactic path in which each topic will address one of the relevant aspects in the knowledge of a highly competent professional. All this makes up a high educational intensity and unmatched quality syllabus, which includes theory and state-of-the-art virtual practice, and that will propel you to the most complete level of mastery in this area. 

This Advanced Master’s Degree is an unparalleled opportunity to obtain, in a single specialization, all the necessary knowledge in Obesity and Diabetes, including the most recent advances in intervention techniques and protocols"

Module 1. Physiology of Appetite and Weight Control Pathophysiology

1.1. Energy Balance
1.2. Adequate Energy Intake: Estimation of Energy Expenditure

1.2.1. Basal Metabolism
1.2.2. Voluntary and Involuntary Physical Activity
1.2.3. Total Energy Expenditure

1.3. Nutritional Assessment

1.3.1 Dietary Surveys

1.4. Gastrointestinal Hormones in the Regulation of Body Weight

1.4.1. Ghrelin
1.4.2. Obestatin
1.4.3. Cholecystokinin
1.4.4. GLP-1 and Others

1.5. Leptin in Body Weight Regulation
1.6. Metabolic Signals and Weight Control

1.6.1. Blood Sugar Levels
1.6.2. Fats

1.7. Hypothalamic Control of Food Intake
1.8. Adipose Tissue as an Endocrine Organ

1.8.1. Adipogenesis
1.8.2. Fat Cell Function in Obesity

1.9. Gut Microbiota and its Influence on the Development of Obesity
1.10. Healthy Nutrition

Module 2. Etiopathogenesis of Obesity

2.1. Genetic Factors of Obesity 

2.1.1. Monogenic Obesity
2.1.2. Polygenic Obesity

2.2. Epigenetics of Obesity

2.3. Secondary Obesity

2.3.1. Endocrinopathy
2.3.2. Drugs

2.4. Nutritional Genomics

2.4.1. Nutrigenetics
2.4.2. Nutrigenomics

2.5. Environmental Factors and Obesity (i): Changes in Eating Pattern
2.6. Environmental Factors and Obesity (ii): Changes in Physical Activity
2.7. Endocrine Disruptors: Obesogens
2.8. Socioeconomic Status and Obesity. Environment and Obesity
2.9. Chronodisruption and Obesity
2.10. Sarcopenic Obesity

Module 3. History Definition. Diagnosis and Classification. Epidemiology

3.1. Definition. Obesity through the Ages
3.2. Diagnosis 

3.2.1. Body Mass Index
3.2.2. Waist Circumference
3.3.3. Body Composition

3.3. Classification Based on Impact of Disease

3.3.1. ABCD 
3.3.2. Edmonton Obesity Staging System

3.4. Epidemiology of Childhood Obesity
3.5. Epidemiology of Adult Obesity
3.6. Phenotypic Characterization of Obese Patients

3.6.1. Body composition
3.6.2. Energy Expenditure
3.6.3. Associated Comorbilities
3.6.4. Compulsive Score

3.7. Epidemiology of the Complications
3.8. Obesity in Different Stages of Life
3.9. Metabolically Healthy Obese People
3.10. New Technologies in Obesity Management

Module 4. Comorbidities of Obesity

4.1. Diabetes Mellitus Type 2 and Obesity

4.1.1. Diabesity
4.1.2. Pathophysiology
4.1.3. Prediabetes

4.2. Arterial Hypertension and Obesity

4.2.1. Mechanisms

4.3. Dyslipidemia and Obesity

4.3.1. Atherogenic Dyslipidemia
4.3.2. Pathogenesis

4.4. Metabolic Syndrome. Heart Disease. Peripheral Vascular Disease and Peripheral Venous Insufficiency

4.4.1. Diagnostic Criteria in Metabolic Syndrome

4.5. Obesity and Cancer

4.5.1. Molecular Mechanisms

4.6. Respiratory Disorders and Obesity

4.6.1. Apnea-hypopnea Syndrome Associated with Obesity
4.6.2. Obesity Hypoventilation Syndrome
4.6.3. Bronquial Asthma

4.7. Digestive Diseases and Obesity

4.7.1. Non-alcoholic Steatohepatitis
4.7.2. Gastroesophageal Reflux Diseases
4.7.3. Colelitiasis

4.8. Gonadotropic Axis and Obesity
4.9. Other Pathologies Associated to Obesity (articular, etc.)
4.10. Obesity and the COVID-19 Pandemic

Module 5. Prevention of Obesity and its Comorbidities

5.1. Childhood Obesity
5.2. Prevention of Childhood Obesity: (i) Importance of Physical Exercise
5.3. Prevention of Childhood Obesity: (Ii) Importance of Education and Treatment
5.4. Women and Weight Control
5.5. Strategies for the Prevention of Overweight and Obesity

5.5.1. International Strategies

5.6. The Heart and Diabetes

5.6.1. Evaluation of Cardiovascular Risk

5.7. Basis of the Therapeutic Approach
5.8. Multidisciplinary Team in the Treatment of Obesity
5.9. Health Systems Costs of Obesity
5.10. Cities and Obesity: Cities Alliance Against Obesity

Module 6. Dietary Treatment of Obesity

6.1. Carbohydrates and Proteins in the Prevention and Treatment of Obesity
6.2. Dietary Fat and its Role in Body Weight Regulation
6.3. Balanced Low-Calorie Diet. Eating Patterns

6.3.1. Nutrient Distribution

6.4. Exchange Diet

6.4.1. Plan
6.4.2. Menus

6.5. The Mediterranean Diet: Prevention and Treatment of Obesity

6.5.1. PREDIMED

6.6. Food Groups: ‘Light’ and Functional Foods

6.7. Magic or Miracle Diets

6.7.1. Dissociated Diets
6.7.2. Exclusion Diets
6.7.3. Fasting Diet

6.8. Very Low-Calorie Diet
6.9. Diets and Maintaining Weight Lost
6.10. Diet in the Treatment of Comorbidities

Module 7. Physical Activity and Obesity

7.1. Influence of Physical Activity on Energy Balance
7.2. Functional Assessment of an Obese Patient

7.2.1. Motor Skills
7.2.2. Flexibility
7.2.3. Muscular Strength
7.2.4. Cardio-respiratory 

7.3. Functional Assessment of Obesity Comorbidities
7.4. Quantification of Physical Activity (Questionnaires, Records, etc.)
7.5. Types of Physical Exercise in the Treatment of Obesity

7.5.1. Aerobic
7.5.2. HIIT
7.5.3. Strength Training

7.6. Principles of Physical Exercise

7.6.1. Frequency (F)
7.6.2. Duration
7.6.3. Intensity

7.7. Physical Activity in Childhood and Adolescence in the Prevention of Overweight and Obesity
7.8. Physical Activity: Guidelines and Consensus
7.9. Cardio-respiratory Rehabilitation and Mechanics of Obese Patients. Rehabilitation after Bariatric Surgery
7.10. Importance of Physical Activity in Maintaining Weight

Module 8. Psychological and Psychiatric Aspects of Obesity

8.1. Body Image, Social Stereotypes and Stigmatization of Obesity

8.1.1. Obesity Throughout History
8.1.2. Dieting and the Slimming Industry

8.2. Role of Emotional Factors, Anxiety Disorders, Mood Disorders and ADHD in Obesity

8.2.1. Eating to Alleviate Psychological Distress
8.2.2. Anxiety
8.2.3. Depression
8.2.4. ADHD
8.2.5. Other Psychological Factors

8.3. Disorders of Eating and Eating Behavior and Food Intake (DSM 5)

8.3.1. Snacking
8.3.2. Rumination Disorder
8.3.3. Food Avoidance/Restriction of Food Intake Disorder
8.3.4. Anorexia Nervosa
8.3.5. Bulimia Nervosa
8.3.6. Binge Eating Disorder
8.3.7. Other Conditions: Night Eating Syndrome

8.4. Explanatory Models, Differential Diagnosis and Management of Eating Disorders Comorbid to Obesity

8.4.1. Obesity, Binge Eating Disorder and the Theory of Dietary Restraint

8.5. Techniques to Promote Motivation to Change

8.5.1. Importance of the Therapeutic Relationship
8.5.2. Transtheoretical Model of Prochaska and DiClemente
8.5.3. Motivational Interview of Miller and Rollnick

8.6. Psychological Assessment in Bariatric Surgery

8.6.1. Areas of Evaluation and Contraindications

8.7. Psychological Intervention in the Treatment of Obesity in Adults

8.7.1. Cognitive-Behavioural Treatment Program. Effective Techniques
8.7.2. Relapse Prevention

8.8. Treatment Programs in Group Format

8.8.1. Intervention Focused on Cognitive Distortions
8.8.2. Self-Help Groups

8.9. Psychological Intervention in Childhood Obesity

8.9.1. Habit and Behaviour Modifications

8.10. Obesity and Eating Disorders Prevention

8.10.1. Early Identification of Risk Factors
8.10.2. Prevention Workshops

Module 9. Pharmacological Treatment of Obesity 

9.1. Orlistat

9.1.1. Xendos Study

9.2. Liraglutide

9.2.1. Scale Study

9.3.  Naltrexone/Bupropion

9.3.1. COR Study

9.4. Anti-obesity Drugs: When to Use Them and How Long to Use Them

9.4.1. Treatment Algorithms

9.5. Commercialized Drugs in Europe
9.6. Non-Commercialized Drugs in Europe
9.7. Drugs Causing Unintentional Weight Loss
9.8. Miracle Drugs
9.9. Future Treatments for Obesity
9.10. Pharmacokinetic Modifications in the Obese Patient Before and After Bariatric Surgery

Module 10. Surgical Treatment of Obesity 

10.1. Evidence Levels
10.2. Indications and Contraindications
10.3. Preoperative Evaluation and Patient Selection
10.4. Surgical Techniques

10.4.1. Malabsorptive
10.4.2. Restrictive
10.4.3. Mixed

10.5. Metabolic and Adaptive Surgery
10.6. Complications of Bariatric Surgery
10.7. Emergencies in Bariatric Surgery
10.8. Postoperative Aftercare
10.9. Gestation After Bariatric Surgery
10.10. Future of Bariatric Surgery

Module 11. The Concept of Diabetes. Epidemiology

11.1. Diabetes Historical Recollection
11.2. Classification of Diabetes and Other Categories of Glucose Intolerance
11.3. Gestational Diabetes
11.4. Diabetes and Genetic Syndromes
11.5. Diabetes and Exocrine Pancreatic Diseases
11.6. Pharmacological Diabetes
11.7. Epidemiology of Type 1 Diabetes
11.8. Epidemiology of Type 2 Diabetes
11.9. Type 2 Diabetes and Prediabetes Screening
11.10. Diabetes and Population Health

Module 12. Pathophysiology of Diabetes

12.1. Normal Anatomy and Physiology of Pancreatic Function. Glucose Homeostasis
12.2. Pathogenesis of Type 1 Diabetes
12.3. Pathogenesis of Type 2 Diabetes. Overview
12.4. Role of Adipose Tissue in Type 2 Diabetes. Concept of Insulin Resistance
12.5. Implications of Intestinal Hormones in the Pathophysiology of Diabetes: Incretin System. Intestinal Microbiota
12.6. Implications of the Kidney in the Pathophysiology of Diabetes
12.7. The Central Nervous System and the Pathophysiology of Diabetes
12.8. Diabetes and Genetics
12.9. Diabetes and Delay or Prevention of DM1
12.10. Diabetes and Delay or Prevention of DM2

Module 13. Evaluation of Diabetes and its Comorbidities

13.1. Patient-Centered. Facilitating Behavioral Change in Patients with Diabetes 
13.2. Glycemic Control Objectives
13.3. Hypoglycemia
13.4. Diabetes and Hyperglycemic Decompensations: CAD
13.5. Diabetes and Hyperosmolar Hyperglycemic Decompensation
13.6. Diabetes and Infections
13.7. Cardiovascular Risk Assessment in Diabetic Patients
13.8. Diabetes and Endocrine Diseases
13.9. Psychological and Social Aspects of Diabetes

Module 14. Diabetes complications. Classification

14.1. Classification of Diabetes Complications and their Impact on the Person with Diabetes 
14.2. Pathophysiology of Microvascular Complications
14.3. Pathophysiology of Macrovascular Complications
14.4. Diabetic Retinopathy
14.5. Diabetic Neuropathy
14.6. Diabetic Nephropathy
14.7. Periodontal Disease
14.8. Erectile Dysfunction
14.9. Diabetic Dermatopathy
14.10. Diabetic Foot

Module 15. Macrovascular Complications of Diabetes and Other Medical Entities

15.1. Epidemiology of Macrovascular Disease in Diabetes
15.2. Epidemiology of Hypertension and Dyslipidemia in Diabetes
15.3. Diabetes and Heart
15.4. Cerebrovascular Disease in Diabetes
15.5. Peripheral Arterial Disease
15.6. Effects of Glycemic Control on Cardiovascular Events in Patients with Diabetes
15.7. Diabetes and Hepatic Steatosis/Steatohepatitis
15.8. Diabetes and Lung Disease
15.9. Diabetes and Cancer
15.10. Diabetes and Depression

Module 16. Diabetes Management (I)

16.1. Introduction to Comprehensive Diabetes Management
16.2. Management of Obesity in Diabetes and Prediabetes. Metabolic Surgery for Diabetes Treatment
16.3. Treatment of Risk Factors: Hypertension in Diabetes, Dyslipidemia
16.4. Treatment of Risk Factors: Tobacco use
16.5. Nutrition in Type 1 Diabetes
16.6. Nutrition in Type 2 Diabetes
16.7. Exercise as Part of Diabetes Treatment
16.8. Conventional Treatment of Type 1 Diabetes
16.9. Non-Conventional Treatment of Type 1 Diabetes. Pancreatic Islet Transplant. Pancreas Transplant
16.10. National and International Guidelines and Consensus on the Management of Type 2 Diabetes

Module 17. Diabetes Management (II)

17.1. Metformin
17.2. Sulfonylureas and Glinides
17.3. Acarbose and Thiazolidines
17.4. Glycosurics
17.5. DPP4 Enzyme Inhibitors
17.6. GLP-1 Receptor Agonists
17.7. Recap. Prandial Insulins. Basal Insulins
17.8. New Treatments in Research
17.9. Steroid Diabetes Treatment
17.10. Treatment of Gestational Diabetes

Module 18. Diabetes and Technology

18.1. Overview of the Use of Technology in Diabetes
18.2. Capillary Glycemia Self-Monitoring
18.3. Continuous Glucose Monitoring. Glucose Sensors
18.4. Insulin and Injection Devices. Insulin Pumps
18.5. Artificial Pancreas
18.6. Use of Technology in Diabetes in Pregnancy
18.7. Use of Technology in Diabetes in Infancy
18.8. Diabetes and Big Data
18.9. Diabetes and Internet (Web, Apps...)
18.10. New Ways to Care for the Diabetes Patient

Module 19. Diabetes in Special Situations

19.1. Diabetes in Childhood and Adolescence
19.2. Diabetes, Alcohol and Sexual Relationships
19.3. Diabetes in Women
19.4. Diabetes in the Elderly and in the Institutionalized Patient
19.5. Diabetes and Sports
19.6. Diabetes in the Hospitalized Patient
19.7. Diabetes and Travel
19.8. Diabetes and Work Life/Rural
19.9. Socioeconomic Aspects of Diabetes
19.10. Legal Aspects of Diabetes

Module 20. Diabetic Education. Concept and Fundamentals

20.1. Diabetic Education. Concept. Assessment of the Educational Needs of the Person with Diabetes
20.2. Diabetology Education Training Programs
20.3. Education and Competencies in People with Type 1 Diabetes
20.4. Education and Competencies in People at Risk of Type 2 Diabetes or with Type 2 Diabetes
20.5. Therapeutic Education of the Child and Adolescent, their Parents or Caregivers
20.6. Therapeutic Education for the Detection of Foot Risk in People with Diabetes
20.7. Impact of the "Expert Patient" Program on Diabetology Education
20.8. Impact of Patients' Associations
20.9. Ethical Aspects in Diabetes Education
20.10. Challenges in Chronic Monitoring. Barriers to Adherence and Therapeutic Inertia

Make the most of this opportunity to learn about the latest advances in this subject to apply it to your daily practice"